US Stock MarketDetailed Quotes

Cytek Biosciences (CTKB)

Watchlist
  • 4.040
  • -0.080-1.94%
Close May 12 16:00 ET
  • 4.282
  • +0.242+6.00%
Post 17:21 ET
521.74MMarket Cap-6.97P/E (TTM)

Cytek Biosciences (CTKB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2,088.80%-2.74M
-118.46%-4.69M
-138.61%-771K
-129.48%-3.9M
-98.26%108K
-103.16%-125K
380.57%25.38M
-79.01%2M
411.89%13.22M
317.68%6.2M
Net income from continuing operations
-65.46%-18.87M
-1,005.30%-66.54M
-557.08%-44.08M
-682.77%-5.48M
46.49%-5.58M
-84.83%-11.4M
50.44%-6.02M
75.23%9.64M
114.56%940K
-137.78%-10.43M
Operating gains losses
13.79%-1.2M
-1.98%-5.26M
26.95%-1.15M
-0.40%-1.25M
-24.19%-1.46M
-20.52%-1.39M
22.51%-5.16M
-12.97%-1.58M
19.82%-1.25M
44.54%-1.18M
Depreciation and amortization
-2.46%2.81M
14.16%11.98M
11.02%3.04M
8.94%3.06M
20.48%2.99M
17.24%2.88M
13.65%10.49M
13.03%2.74M
9.77%2.81M
1.43%2.48M
Deferred tax
45.54%-183K
1,262.75%33.56M
1,436.66%38.58M
---2.63M
---2.06M
---336K
---2.89M
---2.89M
--0
--0
Other non cash items
27.70%189K
95.44%-328K
90.12%-761K
116.92%141K
-1.37%144K
-50.83%148K
-556.06%-7.19M
-2,996.24%-7.7M
-86.46%65K
-49.13%146K
Change In working capital
197.06%9M
-162.15%-4.79M
36.82%-3.48M
-209.33%-3.56M
-109.68%-785K
64.00%3.03M
173.39%7.71M
-43.27%-5.5M
161.85%3.26M
259.15%8.11M
-Change in receivables
49.56%9.65M
106.78%368K
34.12%-6.15M
90.61%-587K
-88.98%652K
52.28%6.45M
25.97%-5.43M
-3,647.15%-9.33M
8.73%-6.25M
187.03%5.92M
-Change in inventory
-8.25%-1.63M
-135.54%-5.24M
2.55%2.05M
-162.49%-2.22M
-180.66%-3.57M
-131.49%-1.5M
244.26%14.76M
-68.42%2M
288.35%3.56M
46.12%4.43M
-Change in prepaid assets
2,685.91%3.85M
5.38%-2.66M
-351.89%-3.35M
142.68%1.11M
-107.79%-270K
94.91%-149K
70.48%-2.81M
89.66%-742K
-413.33%-2.61M
214.34%3.47M
-Change in payables and accrued expense
-104.56%-3.5M
150.31%4.42M
6.38%3.4M
-110.44%-821K
166.87%3.55M
57.05%-1.71M
267.30%1.77M
290.81%3.2M
284.64%7.86M
-52.03%-5.31M
-Change in other current liabilities
60.86%-548K
-22.57%-5.28M
42.37%-1.16M
-25.68%-1.33M
-217.66%-1.39M
-76.32%-1.4M
-26.19%-4.31M
-128.02%-2.02M
-17.28%-1.06M
23.24%-436K
-Change in other working capital
-12.51%1.18M
-3.64%3.6M
24.62%1.74M
-83.88%284K
495.00%238K
147.79%1.34M
-42.68%3.74M
300.14%1.39M
17.86%1.76M
-99.31%40K
Cash from discontinued investing activities
Operating cash flow
-2,088.80%-2.74M
-118.46%-4.69M
-138.61%-771K
-129.48%-3.9M
-98.26%108K
-103.16%-125K
380.57%25.38M
-79.01%2M
411.89%13.22M
317.68%6.2M
Investing cash flow
Cash flow from continuing investing activities
-386.49%-27.08M
112.19%10.12M
97.10%-1.84M
219.69%18.92M
-911.82%-16.42M
264.27%9.45M
11.63%-82.97M
-318.24%-63.43M
-136.66%-15.81M
-27.53%2.02M
Net PPE purchase and sale
-164.95%-2.16M
-18.38%-3.83M
-14.65%-806K
33.74%-656K
-59.06%-1.55M
-43.92%-816K
30.36%-3.24M
53.13%-703K
25.56%-990K
25.59%-977K
Net intangibles purchase and sale
-1,550.00%-33K
48.04%-106K
-255.56%-32K
-75.00%2K
50.00%-74K
96.36%-2K
-13.97%-204K
85.25%-9K
112.70%8K
-169.09%-148K
Net business purchase and sale
----
--0
----
----
----
----
98.96%-471K
-47,000.00%-471K
--0
--0
Net investment purchase and sale
-342.30%-24.88M
117.78%14.06M
98.39%-1M
232.03%19.58M
-569.88%-14.79M
300.12%10.27M
-79.95%-79.06M
-303.25%-62.25M
-133.31%-14.83M
-24.31%3.15M
Net other investing changes
----
---1K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-386.49%-27.08M
112.19%10.12M
97.10%-1.84M
219.68%18.92M
-911.72%-16.41M
264.27%9.45M
11.63%-82.97M
-318.24%-63.43M
-136.66%-15.81M
-27.53%2.02M
Financing cash flow
Cash flow from continuing financing activities
134.48%3.98M
15.10%-13.43M
66.29%-1.23M
116.06%1.94M
-52.07%-2.6M
-815.75%-11.55M
62.16%-15.82M
89.22%-3.64M
-46.05%-12.08M
-892.13%-1.71M
Net issuance payments of debt
607.13%4.2M
-76.90%837K
-157.60%-1.52M
1,541.48%1.95M
975.35%1.24M
-165.98%-828K
741.42%3.62M
1,990.00%2.65M
2.17%-135K
-0.71%-142K
Net common stock issuance
--0
30.25%-15.07M
100.49%34K
100.24%29K
-68.91%-4.51M
---10.63M
51.05%-21.61M
79.88%-6.99M
-41.79%-11.95M
---2.67M
Proceeds from stock option exercised by employees
-46.15%21K
-45.79%1.47M
-36.41%531K
-6.80%137K
-37.69%767K
-92.29%39K
-18.18%2.72M
-32.11%835K
-66.67%147K
-15.04%1.23M
Net other financing activities
-85.27%-239K
-20.76%-669K
-105.38%-267K
-17.12%-171K
21.54%-102K
12.84%-129K
-32.22%-554K
-27.45%-130K
2.01%-146K
-17.12%-130K
Cash from discontinued financing activities
Financing cash flow
134.48%3.98M
15.11%-13.43M
66.32%-1.23M
116.06%1.94M
-52.07%-2.6M
-815.75%-11.55M
62.16%-15.82M
89.22%-3.64M
-46.05%-12.08M
-892.13%-1.71M
Net cash flow
Beginning cash position
-7.99%90.85M
-41.09%98.75M
-42.53%93.28M
-57.58%75.47M
-43.66%95.3M
-41.09%98.75M
-44.03%167.63M
-0.81%162.3M
35.25%177.92M
27.76%169.14M
Current changes in cash
-1,064.74%-25.83M
89.10%-8M
94.10%-3.84M
215.63%16.97M
-390.22%-18.91M
-1,105.43%-2.22M
43.71%-73.42M
-1,449.00%-65.08M
-147.93%-14.67M
4,076.28%6.52M
Effect of exchange rate changes
152.61%646K
-97.59%109K
-6.98%1.41M
189.71%846K
-140.72%-921K
-172.45%-1.23M
413.63%4.53M
284.45%1.52M
-163.98%-943K
324.85%2.26M
End cash Position
-31.10%65.67M
-7.99%90.85M
-7.99%90.85M
-42.53%93.28M
-57.58%75.47M
-43.66%95.3M
-41.09%98.75M
-41.09%98.75M
-0.81%162.3M
35.25%177.92M
Free cash flow
-405.84%-4.94M
-141.00%-8.88M
-264.90%-1.8M
-137.26%-4.55M
-130.84%-1.54M
-129.27%-976K
4,668.72%21.65M
-86.24%1.09M
316.94%12.22M
218.61%5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2,088.80%-2.74M-118.46%-4.69M-138.61%-771K-129.48%-3.9M-98.26%108K-103.16%-125K380.57%25.38M-79.01%2M411.89%13.22M317.68%6.2M
Net income from continuing operations -65.46%-18.87M-1,005.30%-66.54M-557.08%-44.08M-682.77%-5.48M46.49%-5.58M-84.83%-11.4M50.44%-6.02M75.23%9.64M114.56%940K-137.78%-10.43M
Operating gains losses 13.79%-1.2M-1.98%-5.26M26.95%-1.15M-0.40%-1.25M-24.19%-1.46M-20.52%-1.39M22.51%-5.16M-12.97%-1.58M19.82%-1.25M44.54%-1.18M
Depreciation and amortization -2.46%2.81M14.16%11.98M11.02%3.04M8.94%3.06M20.48%2.99M17.24%2.88M13.65%10.49M13.03%2.74M9.77%2.81M1.43%2.48M
Deferred tax 45.54%-183K1,262.75%33.56M1,436.66%38.58M---2.63M---2.06M---336K---2.89M---2.89M--0--0
Other non cash items 27.70%189K95.44%-328K90.12%-761K116.92%141K-1.37%144K-50.83%148K-556.06%-7.19M-2,996.24%-7.7M-86.46%65K-49.13%146K
Change In working capital 197.06%9M-162.15%-4.79M36.82%-3.48M-209.33%-3.56M-109.68%-785K64.00%3.03M173.39%7.71M-43.27%-5.5M161.85%3.26M259.15%8.11M
-Change in receivables 49.56%9.65M106.78%368K34.12%-6.15M90.61%-587K-88.98%652K52.28%6.45M25.97%-5.43M-3,647.15%-9.33M8.73%-6.25M187.03%5.92M
-Change in inventory -8.25%-1.63M-135.54%-5.24M2.55%2.05M-162.49%-2.22M-180.66%-3.57M-131.49%-1.5M244.26%14.76M-68.42%2M288.35%3.56M46.12%4.43M
-Change in prepaid assets 2,685.91%3.85M5.38%-2.66M-351.89%-3.35M142.68%1.11M-107.79%-270K94.91%-149K70.48%-2.81M89.66%-742K-413.33%-2.61M214.34%3.47M
-Change in payables and accrued expense -104.56%-3.5M150.31%4.42M6.38%3.4M-110.44%-821K166.87%3.55M57.05%-1.71M267.30%1.77M290.81%3.2M284.64%7.86M-52.03%-5.31M
-Change in other current liabilities 60.86%-548K-22.57%-5.28M42.37%-1.16M-25.68%-1.33M-217.66%-1.39M-76.32%-1.4M-26.19%-4.31M-128.02%-2.02M-17.28%-1.06M23.24%-436K
-Change in other working capital -12.51%1.18M-3.64%3.6M24.62%1.74M-83.88%284K495.00%238K147.79%1.34M-42.68%3.74M300.14%1.39M17.86%1.76M-99.31%40K
Cash from discontinued investing activities
Operating cash flow -2,088.80%-2.74M-118.46%-4.69M-138.61%-771K-129.48%-3.9M-98.26%108K-103.16%-125K380.57%25.38M-79.01%2M411.89%13.22M317.68%6.2M
Investing cash flow
Cash flow from continuing investing activities -386.49%-27.08M112.19%10.12M97.10%-1.84M219.69%18.92M-911.82%-16.42M264.27%9.45M11.63%-82.97M-318.24%-63.43M-136.66%-15.81M-27.53%2.02M
Net PPE purchase and sale -164.95%-2.16M-18.38%-3.83M-14.65%-806K33.74%-656K-59.06%-1.55M-43.92%-816K30.36%-3.24M53.13%-703K25.56%-990K25.59%-977K
Net intangibles purchase and sale -1,550.00%-33K48.04%-106K-255.56%-32K-75.00%2K50.00%-74K96.36%-2K-13.97%-204K85.25%-9K112.70%8K-169.09%-148K
Net business purchase and sale ------0----------------98.96%-471K-47,000.00%-471K--0--0
Net investment purchase and sale -342.30%-24.88M117.78%14.06M98.39%-1M232.03%19.58M-569.88%-14.79M300.12%10.27M-79.95%-79.06M-303.25%-62.25M-133.31%-14.83M-24.31%3.15M
Net other investing changes -------1K--------------------------------
Cash from discontinued investing activities
Investing cash flow -386.49%-27.08M112.19%10.12M97.10%-1.84M219.68%18.92M-911.72%-16.41M264.27%9.45M11.63%-82.97M-318.24%-63.43M-136.66%-15.81M-27.53%2.02M
Financing cash flow
Cash flow from continuing financing activities 134.48%3.98M15.10%-13.43M66.29%-1.23M116.06%1.94M-52.07%-2.6M-815.75%-11.55M62.16%-15.82M89.22%-3.64M-46.05%-12.08M-892.13%-1.71M
Net issuance payments of debt 607.13%4.2M-76.90%837K-157.60%-1.52M1,541.48%1.95M975.35%1.24M-165.98%-828K741.42%3.62M1,990.00%2.65M2.17%-135K-0.71%-142K
Net common stock issuance --030.25%-15.07M100.49%34K100.24%29K-68.91%-4.51M---10.63M51.05%-21.61M79.88%-6.99M-41.79%-11.95M---2.67M
Proceeds from stock option exercised by employees -46.15%21K-45.79%1.47M-36.41%531K-6.80%137K-37.69%767K-92.29%39K-18.18%2.72M-32.11%835K-66.67%147K-15.04%1.23M
Net other financing activities -85.27%-239K-20.76%-669K-105.38%-267K-17.12%-171K21.54%-102K12.84%-129K-32.22%-554K-27.45%-130K2.01%-146K-17.12%-130K
Cash from discontinued financing activities
Financing cash flow 134.48%3.98M15.11%-13.43M66.32%-1.23M116.06%1.94M-52.07%-2.6M-815.75%-11.55M62.16%-15.82M89.22%-3.64M-46.05%-12.08M-892.13%-1.71M
Net cash flow
Beginning cash position -7.99%90.85M-41.09%98.75M-42.53%93.28M-57.58%75.47M-43.66%95.3M-41.09%98.75M-44.03%167.63M-0.81%162.3M35.25%177.92M27.76%169.14M
Current changes in cash -1,064.74%-25.83M89.10%-8M94.10%-3.84M215.63%16.97M-390.22%-18.91M-1,105.43%-2.22M43.71%-73.42M-1,449.00%-65.08M-147.93%-14.67M4,076.28%6.52M
Effect of exchange rate changes 152.61%646K-97.59%109K-6.98%1.41M189.71%846K-140.72%-921K-172.45%-1.23M413.63%4.53M284.45%1.52M-163.98%-943K324.85%2.26M
End cash Position -31.10%65.67M-7.99%90.85M-7.99%90.85M-42.53%93.28M-57.58%75.47M-43.66%95.3M-41.09%98.75M-41.09%98.75M-0.81%162.3M35.25%177.92M
Free cash flow -405.84%-4.94M-141.00%-8.88M-264.90%-1.8M-137.26%-4.55M-130.84%-1.54M-129.27%-976K4,668.72%21.65M-86.24%1.09M316.94%12.22M218.61%5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More